Suresh Ramalingam

0:04:50

Winship at Emory Midtown with Matt Ryan and Dr. Suresh Ramalingam

0:01:50

Researcher comment: Positive OS data for osimertinib in FLAURA trial | Suresh Ramalingam

0:01:24

Suresh Ramalingam, MD, provides perspective on the PD-L1 and TMB biomarkers in lung cancer

0:02:54

2023 Distinguished Service Award Winner Suresh Ramalingam | IASLC WCLC

0:01:10

Dr. Suresh Ramalingam on Immune Checkpoint Inhibitors in NSCLC Treatment

0:02:04

Dr. Suresh Ramalingam on Frontline Osimertinib Data in EGFR+ NSCLC

0:00:31

What is Dr. Ramalingam’s vision for the journal Cancer?

0:02:47

Dr Ramalingam on Updates in Lung Cancer Following the 2024 ASCO Annual Meeting

0:01:24

Winship at Emory Midtown to showcase 'The Winship Way'

0:01:01

Suresh Ramalingam, MD, discusses the results of CheckMate 227 in advanced NSCLC patients

0:18:07

2020 Winship Scientific Symposium | Suresh Ramalingam, MD

0:01:18

Winship at Emory Midtown brings together innovative research and patient care

0:01:43

Ramalingam Reflects on New Role as Winship Executive Director

0:02:17

Adding ganetespib improved outcomes in advanced lung adenocarcinoma

0:03:17

Dr. Ramalingam on Winship's cancer research and clinical care

0:16:12

Targeting resistance mutations in EGFR: T790M - Suresh Ramalingam

0:00:41

Dr. Ramalingam's message for Winship oncology nurses

0:00:47

Suresh Ramalingam, MD, on how the FLAURA trial may impact care for EGFR-mutated NSCLC

0:01:21

Dr. Suresh S. Ramalingam on Optimizing Immunotherapies in Lung Cancer

0:01:51

#WCLC19 Thought Leader Interview: Dr. Suresh Ramalingam

0:01:16

Suresh Ramalingam, MD, offers opinion on optimal sequencing of immunotherapy in NSCLC

0:00:44

PRECISCA | From The Expert : Suresh Ramalingam, MD

0:07:12

A New Standard of Care: Dr. Ramalingam Discusses LAURA Results, Implications With the Two Onc Docs

0:01:08

Dr. Ramalingam on the OS Results of the FLAURA Trial in EGFR-Mutant NSCLC